INTRODUCTION
Glycoproteins are present in essentially all biological sources from viruses to higher animals, and fulfil a variety of biological functions. Certain cellular functions require the oligosaccharide portion of glycoproteins, including receptor-mediated pinocytosis by the galactose receptor in liver, in which recognition ofthe carbohydrate moiety of circulating glycoproteins determines their removal from the circulation (Struck & Lennarz, 1980) . The proper intracellular compartmentalization of lysosomal hydrolases also depends on the structure of the oligosaccharide moiety ofthese glycoproteins (for review, see von Figura & Hasilik, 1986) . In comparisons of transformed cells with normal cells, there appear to be alterations on the outer chains of oligosaccharide structures of cell-surface glycoproteins and also changes in the activities of the enzymes responsible for catalysing the transfer of these sugar moieties (Chatterjee & Kim, 1977; Patt et al., 1975). 4f6-Galactosyltransferase (EC 2.4.1.38 ) is the most studied of the galactosyltransferases involved in glycoprotein biosynthesis. This enzyme is involved in the addition of galactose to N-acetylglucosamine (in a fl1,4-anomeric configuration) of glycolipids, proteoglycans and 0-and N-linked glycoprotein oligosaccharides. 4,8-Galactosyltransferase is usually membrane-associated, although soluble forms of the enzyme have been found in milk (Brew et al., 1968) , serum (Fujita-Yamaguchi & Yoshida, 1981) and saliva (Humphreys-Beher et al., 1984) . Membrane-associated galactosyltransferase has classically been localized to the Golgi apparatus (Schachter & Roseman, 1980; Smith & Brew, 1977) , but a portion of the cellular activity has been found at the cell surface (Roth et al., 1971; Pierce et al., 1980) . Numerous reports have shown that alteration of cell-surface galactosyltransferase activity might be involved in cell adhesion (Roth et al., 1971 ; Roseman, 1970) , recognition (Pierce et al., 1980) , differentiation (Weiser, 1973) and embryogenesis (Shur, 1982) . The correlation of altered galactosyltransferase activities is particularly intriguing, because of their possible role in transformation via alterations in cell-surface recognition (Roth et al., 1977; Higgins & Anderson, 1981; Klohs et al., 1982) .
The chronic administration of isoprenaline (a /?-adrenergic-receptor agonist) results in physiological changes, which include parotid-gland cell hypertrophy and hyperplasia. At the molecular level, DNA, RNA and protein syntheses are all increased after isoprenaline administration, probably due in part to the mediation of cyclic nucleotides (Barka, 1965; Grand & Schay, 1978; Ludford & Talamo, 1983) , since the addition of a ,-antagonist blocks these changes. The introduction of high doses of phosphodiesterase inhibitors such as theophylline and caffeine (Wells & Humphreys-Beher, 1985) as well as certain hormones (Medina et al., 1984; Imai et al., 1982) will also cause parotid-gland hypertrophy and changes in parotid-gland gene expression. Such agents cause an increase in enzyme activity for Nacetylglucosamine 4,f-galactosyltransferase, even though a second enzyme activity, N-acetylgalactosamine 3,/-galactosyltransferase (or mucin transferase), remains unchanged (Humphreys-Beher et al., 1984) .
We have previously shown that isoprenaline causes increased synthesis of the mRNA for the 4,f-galactosyltransferase as well as causing topographical re-arrangements of the enzyme and the secretion of active enzyme into saliva (Humphreys-Beher et al., 1984 (Linquest, 1980; Greenberg & Perry, 1971) . Finally, a third group of cells received actinomycin D or cycloheximide for 3 h, were washed free of the inhibitors, and were then incubated for an additional 3 h in fresh media containing isoprenaline to re-initiate 4,-galactosyltransferase transcription.
In a separate series of experiments, the degradation of 4fl-galactosyltransferase mRNA was measured over a 3 h period after the induction of active isoprenalineinduced transcription by a prior 3 h incubation in media containing 1 /tM-isoprenaline. After the incubation periods described above, cells were lysed into a guanidine isothiocyanate mixture for RNA isolation (Chirgwin et al., 1979) . For galactosyltransferase enzyme assays, the cells were rinsed of media with phosphate-buffered saline (Oliver et al., 1987) . The cells were then liberated from the surface of plastic dishes with 1.0 ml of phosphatebuffered saline containing 0.5% Triton X-100. The resulting slurry was removed by Pasteur pipette, and a protein assay performed by the modified Lowry assay of Schacterle & Pollack (1983) . Bovine serum albumin was used as a protein standard.
Galactosyltransferase assays
The activity of 4,-galactosyltransferase was measured as previously described by Humphreys-Beher et al. (1984) . In brief, cell lysates were obtained as described above and resuspended to give a final protein concentration of 200 ,g/ml. The assay mixture (total volume 50 ,ul) contained 0.1 M-Mes (pH 6.3), 25 mM-MnC12, 0.5% Triton X-100, 1 mM-UDP[1-4C]galactose (2 mCi/ mmol), 10 mM-ovalbumin (for 4fl-transferase) or asialo-(bovine submaxillary mucin) (for 3fl-transferase) as acceptor, and 0-0.2 mg of the cell lysate. After incubation for 1 h, the reaction was terminated by the addition of 1 ml of ice-cold 10 % (v/v) trichloroacetic acid, and the precipitate was recovered on glass-fibre filters. Northern and dot-blot analysis of 4pIgalactosyltransferase RNA Parotid-gland total RNA was recovered by ultracentrifugation in a Beckman SW50.1 rotor as described previously (Humphreys-Beher et al., 1984) . Poly(A)-containing RNA was recovered after oligo(dT)-cellulose chromatography (Aviv & Leder, 1972) . The 10 ,ug of denatured poly(A)-containing RNA was electrophoresed on a formaldehyde denaturing gel, and the RNA was transferred to nitrocellulose filters as described by White & Bancroft (1980) . Hybridization was performed at 37°C with 2.5 x 107 c.p.m. of nick-translated 32P-labelled 4,-galactosyltransferase (Humphreys-Beher et al., 1986) or fl-tubulin (Cowan et al., 1981; Cleveland et al., 1980) cDNA probes.
For RNA dot-blot analysis, 30,g portions of formaldehyde-denatured total RNA from control and experimental parotid-gland acinar-cell cultures were spotted on nitrocellulose filters with a Schleicher and Schuell mini-fold apparatus as described by White & Bancroft (1980) . The filters were then probed with the 32P-labelled nick-translated human 4fl-galactosyltransferase cDNA (Humphreys-Beher et al., 1986; Bunnell et al., 1987) . Conditions of the hybridization and autoradiography were as described previously (Chandra et al., 1983; Humphreys-Beher et al., 1986) .
RESULTS
Chronic administration of the fl-adrenergic-receptor agonist isoprenaline in rats causes a 6-10-fold increase in both the specific activity and steady-state amounts of mRNA for the Golgi-membrane marker enzyme 4,6-galactosyltransferase (Humphreys-Beher et al., 1984 . To investigate further the isoprenaline-mediated regulation of gene expression for this enzyme, parotidgland acinar cells were isolated from rats and cultured in vitro by the method ofOliver et al. (1987) . The cells were cultured at 37°C for 48 h to allow attachment to the gel matrix. After this time fresh medium containing 1 /UMisoprenaline was applied to the cells, and incubation was continued for 3 h before harvesting. As shown in Table  1 , the addition of isoprenaline to the culture media resulted in a 6-fold increase in specific activity for the 4,6-galactosyltransferase enzyme. A second galactosyltransferase enzyme activity, the 3,6-galactosyltransferase (no EC number), remained unchanged in the presence of isoprenaline. This same result has previously been shown from whole-animal studies with chronic isoprenaline treatment of parotid glands (Humphreys-Beher, 1985) . The introduction of the transcriptional inhibitor actinomycin D or the protein translation inhibitor cycloheximide along with isoprenaline prevented the increase in 4,8-galactosyltransferase activity (Table 1 ). The concentration of inhibitor used in each case was determined 4/3-Galactosyltransferase-gene expression 1.7 kb in size. The increase in the amount of 1.7 kb species was confirmed by densitometer scanning (Fig. 1) . This result is similar to the 6-fold increase observed by direct enzyme assay. The autoradiograph for galactosyltransferase cDNA hybridization was overexposed in an attempt to identify the existence of any other mRNA species that may have been induced by isoprenaline. The same RNAs were also probed with a ,-tubulin cDNA probe as a control (Cowan et al., 1981; Cleveland et al., 1980) , and equivalent hybridization signals were seen in both samples (Fig. 1) (Fig. 2) . This was most likely due to (a) (b) (Fig. 2) .
The rate of decline in steady-state amounts of 4fl-galactosyltransferase RNA in acinar cells induced with isoprenaline for 3 h was measured after the cells were transferred to media containing either cycloheximide or actinomycin D. As shown in Fig. 2, 4fl- Isoprenaline imparts its influence on acinar-cell function through the second messenger cyclic AMP. The activation of adenylate cyclase by isoprenaline results in a large number of cellular changes that are affected by the corresponding increase in cyclic AMP. Therefore, it may be postulated that the increased steady-state amounts of 4fl-galactosyltransferase mRNA after isoprenaline treatment result from alterations in the rate of mRNA turnover. The introduction of the proteinsynthesis inhibitor cycloheximide may prevent the synthesis of a factor involved in mRNA degradation. The addition of isoprenaline to acinar cells results in the biosynthesis, or increases the half-life, of a cellular factor that regulates the rate of 4,8-galactosyltransferase mRNA turnover. Cycloheximide would interfere with the synthesis of the protein which would need to be present continuously to affect mRNA stability. Since the presence of cycloheximide in control cell cultures did not result in an increase in steady-state mRNA amounts, this interpretation does not appear to be valid.
Cyclic AMP has been shown to cause transcriptional changes in a number of cellular genes, which in parotidgland acinar cells include the proline-rich-protein gene family (Ann & Carlson, 1985) . Unlike the activation of transcription by steroid hormones (Yamamoto, 1985) , ,-agonists do not traverse the plasma membrane coupled to fl-adrenergic receptors. The activation of RNA transcription may reside in the direct interaction of either cyclic AMP or cyclic AMP-dependent DNA-binding proteins with DNA to promote gene expression in response to the agonist. For 4,/-galactosyltransferasegene expression to occur, isoprenaline may initiate the synthesis of a tissue-specific factor that causes increased transcription from the transferase-gene promoter. There is accumulating evidence that transcriptional activity of various genes requires the presence of tissue-specific factors that bind to specific DNA sequences to exert their influence (Mercola et al., 1985; Scholer & Gruss, 1984 
